[Which tumor markers should be used in primary bronchial cancers?].
Schuller
M P
MP
Service de Pneumologie, Hôpital St-Antoine, Paris.
Carrat
F
F
Urban
T
T
Lebeau
B
B
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis*; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D008175:Lung Neoplasms / Q000175:diagnosis*; D010751:Phosphopyruvate Hydratase; D012680:Sensitivity and Specificity
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins; D010751:Phosphopyruvate Hydratase